Colorectal cancer (CRC) represents currently the third most frequent type of cancer and is amongst the leading causes of cancer-related death worldwide. Approximately every second patient develops liver metastases (LM). Resection of these metastases has become the most common indication for liver resection. In the era of multimodal treatment, surgical resection of colorectal LM still plays a crucial role in achieving long-term survival. Despite the well-known range of benefits offered by minimally invasive surgery, laparoscopic liver surgery struggles to replace open surgery in daily practice. However, over the last decades, the number of major and technically more demanding laparoscopic liver resections steadily increased. Besides, the increasing amount of data on intra- and postoperative outcomes, on oncological surrogate markers like R0 resection as well as on long-term outcomes like recurrence free and overall survival supports the minimally invasive approach in liver surgery. This review aims to provide a short general overview of current treatment strategies for colorectal LM and to summarize the contemporary literature on laparoscopic resection of these metastases focusing especially on retrospective data using propensity score adjustments and on recently published prospective randomized trials. Available data clearly show that laparoscopic resection of colorectal LM results in better short-term outcomes like reduced perioperative morbidity and mortality. Of note, oncological long-term outcomes seem to be at least equivalent to the open procedures. Still, most available data are from highly specialized centers, and prospective randomized controlled trial data on long-term results are lacking. While eagerly waiting for these data, implementation of laparoscopic liver surgery should be fostered as minimally invasive techniques will be integral part of the future.